Limitations, agreements, and source contact

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck · Source last updated 2026-10-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

Adam.Luginbuhl@jefferson.edu

organization

Sidney Kimmel Comprehensive Cancer Center

phone

215-955-6760

title

Adam Luginbuhl, MD

Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0

Preserved source evidence · Not medical advice